Phio Pharmaceuticals (PHIO) Other Non Operating Income (2011 - 2026)
Phio Pharmaceuticals' (PHIO) quarterly Other Non Operating Income came in at $3000.0 in Q1 2026, up 113.64% YoY from $1404.3 in Q1 2025, and up 113.64% on a QoQ basis from -$22000.0 in Q1 2025.
Phio Pharmaceuticals (PHIO) Other Non Operating Income (2011 - 2026) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 9 years of Other Non Operating Income data on file, last reported at $3000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 113.64% year-over-year to $3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19000.0 (up 98.8% YoY) and the FY2022 annual result came in at -$553000.0, up 58.39% from the prior year.
- Other Non Operating Income grew to $3000.0 in Q1 2026, from -$22000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $3000.0 in Q1 2026 to a low of -$22000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Phio Pharmaceuticals | 13.77 Mn | 13.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Mar 31, 2025 | -22,000.00 |
| Dec 31, 2021 | -1.56 Mn |
| Mar 31, 2021 | 233,000.00 |
| Jun 30, 2016 | -1,000.00 |
| Mar 31, 2016 | 7,000.00 |
| Jun 30, 2015 | -2,000.00 |
| Sep 30, 2014 | -1,000.00 |
| Jun 30, 2014 | 10,000.00 |
| Sep 30, 2013 | 2,000.00 |
| Mar 31, 2013 | -3,000.00 |
| Dec 31, 2012 | 1,000.00 |
| Sep 30, 2012 | 53,000.00 |
| Jun 30, 2012 | 70,000.00 |
| Mar 31, 2012 | 1,000.00 |
| Dec 31, 2011 | 955,000.00 |
| Sep 30, 2011 | 123,000.00 |
| Mar 31, 2011 | 1.44 Mn |